Kyntra Bio (KYNB) Gross Margin (2020 - 2025)
Historic Gross Margin for Kyntra Bio (KYNB) over the last 6 years, with Q3 2025 value amounting to 94.61%.
- Kyntra Bio's Gross Margin rose 555900.0% to 94.61% in Q3 2025 from the same period last year, while for Sep 2025 it was 63.81%, marking a year-over-year decrease of 528400.0%. This contributed to the annual value of 116.12% for FY2024, which is 2076600.0% down from last year.
- Kyntra Bio's Gross Margin amounted to 94.61% in Q3 2025, which was up 555900.0% from 93.69% recorded in Q2 2025.
- In the past 5 years, Kyntra Bio's Gross Margin registered a high of 97.91% during Q3 2021, and its lowest value of 859.09% during Q1 2024.
- For the 5-year period, Kyntra Bio's Gross Margin averaged around 15.48%, with its median value being 77.16% (2022).
- As far as peak fluctuations go, Kyntra Bio's Gross Margin tumbled by -7537400bps in 2024, and later surged by 9450900bps in 2025.
- Kyntra Bio's Gross Margin (Quarter) stood at 81.11% in 2021, then rose by 6bps to 85.67% in 2022, then increased by 2bps to 87.16% in 2023, then dropped by -20bps to 69.69% in 2024, then soared by 36bps to 94.61% in 2025.
- Its last three reported values are 94.61% in Q3 2025, 93.69% for Q2 2025, and 86.0% during Q1 2025.